Drug Shortage Report for PREVYMIS
| Report ID | 233731 |
| Drug Identification Number | 02469405 |
| Brand name | PREVYMIS |
| Common or Proper name | Letermovir for injection |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | LETERMOVIR |
| Strength(s) | 20MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1 x Vial |
| ATC code | J05AX |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2024-08-12 |
| Actual start date | 2024-08-08 |
| Estimated end date | 2024-10-04 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-08-09 |
| Company comments | PREVYMIS SFI 240MG VIAL, PREVYMIS 240MG 4X7TAB & PREVYMIS 480MG 4X7TAB formats remain available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2024-08-09 | French | Compare |
| v6 | 2024-08-08 | French | Compare |
| v5 | 2024-08-08 | English | Compare |
| v4 | 2024-08-02 | French | Compare |
| v3 | 2024-08-02 | English | Compare |
| v2 | 2024-07-26 | French | Compare |
| v1 | 2024-07-26 | English | Compare |
Showing 1 to 7 of 7